Lv1
6 积分 2024-05-29 加入
FRI0430 Comparative effectiveness and health economic evaluation of systemic anti-inflammatory therapies for acute GOUT flares
3小时前
待确认
Polatuzumab Vedotin in Previously Untreated Diffuse Large B-Cell Lymphoma
23天前
已完结
Three-year follow-up analysis of first-line axicabtagene ciloleucel for high-risk large B-cell lymphoma: the ZUMA-12 study
1个月前
已完结
Glofitamab Combined With Pola-R-CHP or R-CHOP as First Therapy in Younger Patients With High-Risk Large B-Cell Lymphoma: Results From the COALITION Study
1个月前
已完结
Rituximab biosimilar HLX01 versus reference rituximab in the treatment of diffuse large B-cell lymphoma: Real-world clinical experience
1个月前
已完结
Value for Money of CAR-T Cell Therapy for Patients with Diffuse Large B-cell Lymphoma in China: Evidence from a Cost-Effectiveness Analysis
1个月前
已完结
Efficacy and relapse profiles of Pola‐R‐ CHP versus R‐ CHOP in previously untreated diffuse large B‐cell lymphoma: A multicentre real‐world study
2个月前
已完结
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
4个月前
已完结
Development and validation of age-specific predictive model on the risk of post-acute mortality within one year of COVID-19 infection
4个月前
已关闭
新医科背景下医学微生物学实验教学改革探索与实践
6个月前
已完结
皖公网安备34019202002308
